Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends

• Hoofdauteurs: Xintian Lyu, BS (Auteur), Sílvia M. Illamola, PharmD, PhD (Auteur), Susan E. Marino, PhD (Auteur), Ilo E. Leppik, MD (Auteur), Stephen Dahmer, MD (Auteur), Paloma Lehfeldt, MD (Auteur), Jeannine M. Conway, PharmD (Auteur), Rory P. Remmel, PhD (Auteur), Kyle Kingsley, MD (Auteur), Angela K. Birnbaum, PhD (Auteur)
• Formaat: Boek
• Gepubliceerd in: Elsevier, 2023-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

ABSTRACT: Background: Little is known about the distribution of cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) to patients participating in state medical cannabis programs. The Minnesota cannabis program requires third-party testing of products with limited formulations of cannabis for distribu...